Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Similar Posts
MHRA updates guidance for semaglutide prescribers and patients
MHRA updates product information regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients taking semaglutide.
Field Safety Notices: 23-27 February 2026
List of Field Safety Notices from 23-27 February 2026.
Guidance: Medicines that you cannot export from the UK or hoard
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Breast implants – patient perception of risk research
Information for patients, public and healthcare professionals
Field Safety Notices: 1 to 5 September 2025
List of Field Safety Notices from 1 to 5 September 2025.
Guidance: COVID-19 test validation approved products
Find out which COVID-19 test products have been approved.